Suppr超能文献

血友病假性肿瘤的临床特征和治疗:30 年来美国单一中心的经验。

Clinical features and management of haemophilic pseudotumours: a single US centre experience over a 30-year period.

机构信息

Division of Hematology/Oncology, Department of Medicine, University of Chapel Hill, Chapel Hill, NC, USA.

出版信息

Haemophilia. 2014 Jan;20(1):e58-62. doi: 10.1111/hae.12295. Epub 2013 Oct 31.

Abstract

Given the rarity of haemophilic pseudotumours, consensus on management is lacking. We describe the clinical features and management of haemophilic pseudotumours by retrospectively reviewing the medical records of haemophilia patients with a diagnosis of pseudotumour seen at our Hemophilia Center from 1981 to 2011. We recorded the following data: type and severity of haemophilia, documented aetiological antecedent, localization of the pseudotumour, presenting symptoms, management and outcome. We identified 12 pseudotumours in 11 patients over a 30-year period. Six patients had known inhibitors or a history of inhibitor. An aetiological antecedent leading to the development of pseudotumour was reported in nine cases. Localization of the pseudotumour was confined to soft tissue (n = 3) and bone (n = 8). Six of the 12 pseudotumours (50%) were not diagnosed at the time of initial presentation, with a delay ranging from 6 weeks to 6 years. In eight cases, surgical intervention (surgical drainage, n = 2; excision, n = 4; limb amputation, n = 2) was the initial treatment choice, with complete resolution in six cases. Conservative management with close monitoring occurred in three cases, with one case subsequently requiring surgical resection. We conclude that haemophilic pseudotumours still occur sporadically, and the diagnosis is frequently delayed. Surgical intervention is generally a safe and effective treatment, although conservative management may be appropriate in selected cases.

摘要

鉴于血友病假瘤的罕见性,目前缺乏对此类疾病的管理共识。我们通过回顾性分析自 1981 年至 2011 年在我院血友病中心就诊的血友病患者的病历,描述血友病假瘤的临床特征和管理方法。我们记录了以下数据:血友病的类型和严重程度、已知的病因学诱因、假瘤的定位、临床表现、治疗方法和转归。我们在 30 年间发现了 11 例 12 个血友病假瘤。其中 6 例患者有已知的抑制剂或抑制剂病史。9 例报告了导致假瘤形成的病因学诱因。假瘤局限于软组织(n = 3)和骨骼(n = 8)。12 个假瘤中有 6 个(50%)在初次就诊时未被诊断,延迟时间从 6 周至 6 年不等。在 8 例中,手术干预(手术引流,n = 2;切除,n = 4;截肢,n = 2)是最初的治疗选择,6 例患者完全缓解。3 例采用密切监测的保守治疗,其中 1 例随后需要手术切除。我们得出结论,血友病假瘤仍会偶尔发生,且诊断常被延误。手术干预通常是一种安全有效的治疗方法,但在某些情况下,保守治疗可能是合适的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验